DOI: https://doi.org/10.22141/2224-0586.3.98.2019.165471

Selection of intravenous fluids for perioperative volemic support

O.O. Volkov, O.M. Klygunenko, V.V. Lutsenko

Abstract


The use of hydroxyethyl starch (HES) has become controversial in the past two decades after increasing the number of studies on critical ill patients, showing that its use was associated with an increased incidence of acute kidney injury (AKI) or even mortality. Some of these studies had significant problems regarding the methodology. For example, in some studies HES was administered before randomization, the assessment of hypovolemia was insufficient, there was a long-term administration of HES, or the volume received exceeded the maximum dose. Infusion agents should be considered as drugs for avoi­ding unnecessary preoperative fasting, infusion-related adverse effects, and it allows creating basic targeted volemic therapy by conducting more in-depth studies. The choice of the fluid type to prevent hyperchloremic metabolic acidosis in the perioperative period and the unfavorable association of HES with hemostasis and renal dysfunction does not allow scientific debate to stop with the designation of a specific scheme of perioperative infusion therapy. This review shows the data of approaches in fluid resuscitation and the effect on the results in the perioperative settings. The choice of the fluid type is a key position due to the high frequency of hyperchloremia, hyperkalemia and metabolic acidosis associated with the use of large volumes of saline, and reports the correlation of HES with blood clotting disorders and renal complications. None of the studies were able to detect the difference in acute kidney damage between the hydroxyethyl starch of the current generation and the crystalloids in surgical patients. The quality and level of evidence in the available lite­rature is too low to conclude whether HES has a favorable or unfavorable profile in the treatment of acute perioperative hypovolemia. When hydroxyethyl starch is used, the recommended dose should not be exceeded, and its use should be limited to non-septic patients without history of renal failure.

Keywords


perioperative period; infusion therapy; colloids; crystalloids; hydroxyethyl starch; review

References


Boer C., Bossers S.M., Koning N.J. Choice of fluid type: physiological concepts and perioperative indications. BJA. 2018; 120(2): 384-396. doi: https: // doi.org/ 10.1016/j.bja.2017.10.022.

Myles, P.S., Andrews, S., Nicholson, J., Lobo, D.N., Mythen, M. Contemporary approaches to perioperative IV fluid therapy. World J Surg. 2017;41:2457–2463.

Meybohm, P., Van Aken, H., De Gasperi, A. et al. Re-evaluating currently available data and suggestions for planning randomised controlled studies regarding the use of hydroxyethyl starch in critically ill patients—a multidisciplinary statement. Crit Care. 2013; 17: R166.

Mclean, D., Shaw, A. Intravenous fluids and their effects on renal outcomes. Br J Anaesth. 2018;120:397–402.

Fenger-Eriksen, C., Tonnesen, E., Ingerslev, J., and Sorensen, B. Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. J Thromb Haemost. 2009; 7: 1099–1105.

Niemi, T.T., Kuitunen, A.H. Artificial colloids impair haemostasis: an in vitro study using thromboelastometry coagulation analysis. Acta Anaesth Scand. 2005;49:373–378.

Rasmussen, K.C., Hojskov, M., Johansson, P.I. et al. Impact of albumin on coagulation competence and hemorrhage during major surgery: a randomized controlled trial. Medicine. 2016; 95: e2720.

Cho, J.E., Shim, J.K., Song, J.W., Lee, H.W., Kim, D.H., and Kwak, Y.L. Effect of 6% hydroxyethyl starch 130/0.4 as a priming solution on coagulation and inflammation following complex heart surgery. Yonsei Med J. 2014; 55: 625–634.

Atasever, B., van der Kuil, M., Boer, C. et al. Red blood cell transfusion compared with gelatin solution and no infusion after cardiac surgery: effect on microvascular perfusion, vascular density, hemoglobin, and oxygen saturation. Transfusion. 2012; 52: 2452–2458

Naumann, D.N., Beaven, A., Dretzke, J., Hutchings, S., and Midwinter, M.J. Searching for the optimal fluid to restore microcirculatory flow dynamics after haemorrhagic shock: a systematic review of preclinical studies. Shock. 2016; 46: 609–622.

Powell, M., Mathru, M., Brandon, A., Patel, R., and Frolich, M. Assessment of endothelial glycocalyx disruption in term parturients receiving a fluid bolus before spinal anesthesia: a prospective observational study. Int J Obstet Anesth. 2014; 23: 330–334.

de Crescenzo, C., Gorouhi, F., Salcedo, E.S., and Galante, J.M. Prehospital hypertonic fluid resuscitation for trauma patients: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2017; 82: 956–962.

Jacob, M., Bruegger, D., Rehm, M., Welsch, U., Conzen, P., and Becker, B.F. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology. 2006; 104: 1223–1231.

Annane, D., Siami, S., Jaber, S. et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013; 310: 1809–1817.

Kim, T.K., Nam, K., Cho, Y.J. et al. Microvascular reactivity and endothelial glycocalyx degradation when administering hydroxyethyl starch or crystalloid during off-pump coronary artery bypass graft surgery: a randomised trial. Anaesthesia. 2017; 72: 204–213.

McCluskey, S.A., Karkouti, K., Wijeysundera, D., Minkovich, L., Tait, G., and Beattie, W.S. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013; 117: 412–421.

Kancir, A.S., Johansen, J.K., Ekeloef, N.P., and Pedersen, E.B. The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial. Anesth Analg. 2015; 120: 608–618.

Rasmussen, K.C., Johansson, P.I., Hojskov, M. et al. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Ann Surg. 2014; 259: 249–254.

Mukhtar, A., Aboulfetouh, F., Obayah, G. et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg. 2009; 109: 924–930.

Lavu, H., Sell, N.M., Carter, T.I. et al. The HYSLAR trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Ann Surg. 2014; 260: 445–453.

Lavu, H., Sell, N.M., Carter, T.I. et al. The HYSLAR trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3% hypertonic saline versus lactated Ringers in patients undergoing pancreaticoduodenectomy. Ann Surg. 2014; 260: 445–453.

Ross, S.W., Christmas, A.B., Fischer, P.E. et al. Impact of common crystalloid solutions on resuscitation markers following class I hemorrhage: a randomized control trial. J Trauma Acute Care Surg. 2015; 79: 732–740

Delano, M.J., Rizoli, S.B., Rhind, S.G. et al. Prehospital resuscitation of traumatic hemorrhagic shock with hypertonic solutions worsens hypocoagulation and hyperfibrinolysis. Shock. 2015; 44: 25–31.

Bulger, E.M., May, S., Kerby, J.D. et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg. 2011; 253: 431–441.

Terkawi, A.S., Larkin, S.K., Tsang, S., Sheeran, J.S., Tiouririne, M. Effects of hydroxyethyl starch 6% (130/0.4) on blood loss during cesarean delivery: a propensity-matched analysis. J Anesth. 2016;30:796–802.

Rossaint, R., Bouillon, B., Cerny, V. et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 100.

Bilotta F. Perioperative Hydroxyethyl Starch: A Potential Threat to Patient Safety. Anesthesia&Analgesia. 2018; 127 (2): e30-e31.

Priebe H.-J. Should hydroxyethyl starch be banned? The Lancet. 2018; 392 (10142): 117-118.




Copyright (c) 2019 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019

 

   Seo анализ сайта